The framework rests on a simple but powerful physiological observation. Every step of the oxygen cascade shows measurable age-related decline. Starting at roughly 21 percent of inspired oxygen at sea level, the partial pressure of oxygen drops sequentially across the alveoli, the arterial blood, the microcirculation, the interstitial space, and the mitochondria. In youth, this cascade is buffered by remarkable resilience: ventilation, cardiac output, capillary recruitment, and mitochondrial function adjust continuously to match oxygen supply with metabolic demand. With age, that adaptive capacity erodes at every level simultaneously. The authors emphasize that Oxygenaging is not simply a state of oxygen deficiency. Rather, it reflects a progressive loss of resilience in the mechanisms that maintain oxygen homeostasis, leaving older organisms increasingly vulnerable to mismatches between oxygen availability and energetic requirements — mismatches that compromise cellular function, tissue integrity, and physiological reserve.

The first step of the cascade, pulmonary gas exchange, deteriorates through well-characterized structural changes. Age-related loss of elastin fibers reduces lung elastic recoil, promoting premature closure of small airways, particularly in gravity-dependent regions of the lung. These poorly ventilated but still perfused units act as functional shunts, widening the alveolar-arterial oxygen gradient and increasing ventilation-perfusion heterogeneity — quantified by the log standard deviation of perfusion distribution, which rises from roughly 0.36 in younger adults to 0.47 in older individuals. Empirical reference equations established decades ago show that age is the single most robust predictor of arterial oxygenation, with arterial oxygen partial pressure falling by approximately 15 to 20 mmHg between mid-life and old age. The review also highlights a less appreciated mechanism: systemic iron deficiency, common in aging, mimics hypoxia at the pulmonary endothelium by inhibiting prolyl hydroxylase domain enzymes, exaggerating hypoxic pulmonary vasoconstriction and placing additional strain on the right ventricle.

The second step, central hemodynamics, compounds the problem. Oxygen delivery is the product of arterial oxygen content and cardiac output, and in aging the decline in maximal heart rate — dropping roughly 25 percent, from about 200 beats per minute in youth to about 150 in old age — becomes the dominant bottleneck on peak oxygen delivery. The aging system also fails to shift the hemoglobin-oxygen dissociation curve rightward at baseline to facilitate tissue oxygen unloading; because systemic 2,3-bisphosphoglycerate levels do not rise with healthy aging, tissues depend heavily on acute stressors such as the heat and acidosis of exercise — the Bohr effect — to release oxygen from hemoglobin. Combined with the flat upper plateau of the dissociation curve, which prevents healthy lung regions from over-compensating for failing ones, these deficits translate into a measurable drop in overall arterial saturation and a progressive constraint on systemic oxygen supply.

The third and arguably most consequential step occurs in the microvasculature. Maximal oxygen uptake, the integrated measure of the entire cascade, falls by approximately 10 percent per decade, limited both by reduced central delivery and by peripheral failure of oxygen extraction. Aging brings microvascular rarefaction, endothelial dysfunction with reduced nitric oxide bioavailability, and increased diffusion distances caused by fibrosis and diminished pericyte coverage. Even when bulk blood flow appears adequate, the aged microvasculature mounts a sluggish hyperemic response to exertion, failing to raise microvascular oxygen pressure precisely when the diffusion gradient into mitochondria is needed most. Notably, the authors point to a metabolic peculiarity of endothelial cells: they rely primarily on glycolysis rather than oxidative phosphorylation, and aging disrupts this specialization, crippling the migratory and proliferative machinery required for angiogenesis. This explains why simply supplementing oxygen may fail to rescue microvascular function in older tissues.

Organ-specific evidence grounds the framework in measurable clinical data. Near-infrared spectroscopy studies show regional cerebral oxygen saturation falling from roughly 69.8 percent in young adults to 62.7 percent in older adults, driven by pericyte degeneration, blood-brain barrier leakage, and uncoupling of endothelial nitric oxide synthase within the neurovascular unit. Renal BOLD-MRI reveals progressive medullary hypoxia as peritubular capillary rarefaction and tubulointerstitial fibrosis enlarge diffusion distances. In skin, transcutaneous oxygen measurements expose a blunted neurogenic vasodilatory response to thermal stress, reflecting extracellular matrix stiffness that mechanically limits vessel expansion. In skeletal muscle, phosphorus-31 magnetic resonance spectroscopy shows that post-exercise phosphocreatine recovery slows from about 37 seconds in young muscle to about 52 seconds in aged muscle, paralleled by reduced mitochondrial content, mild uncoupling via uncoupling protein 3, and instability of respiratory supercomplexes.

At the molecular level, the review describes how the hypoxia-inducible factor system — the ancient oxygen-sensing machinery conserved across metazoans — becomes maladaptive with age. In youth, prolyl hydroxylase domain enzymes use oxygen, alpha-ketoglutarate, and iron to tag HIF-1alpha for degradation, keeping the pathway exquisitely responsive to genuine hypoxia. With aging, declining NAD+ reduces SIRT1 activity and lowers von Hippel-Lindau expression, while accumulating succinate directly inhibits PHD catalytic activity. Both routes converge on the same outcome: stabilization of HIF-1alpha under normal oxygen conditions, a state the authors term chronic pseudohypoxia. This maladaptive activation suppresses mitochondrial biogenesis through the MYC-TFAM axis, impairs mitophagy through lysosomal dysfunction, and leaves a pool of damaged, reactive-oxygen-species-leaking mitochondria. The framework also intersects with iron biology — what the authors call Ferroaging — as an expanded labile iron pool catalyzes the Fenton reaction during reoxygenation, priming vulnerable cells for ferroptosis, an iron-dependent form of cell death.

The consequences ripple through metabolism and the genome. Hyperactive mTOR signaling in aging overrides HIF-1alpha’s normal metabolic brake, forcing cells to continue energy-consuming anabolic growth despite insufficient oxygen. HIF-1alpha-mediated suppression of lipolysis — the so-called lipid lock — promotes triglyceride accumulation and hepatic steatosis. Meanwhile, oxygen availability physically constrains the dioxygenase enzymes that govern the epigenetic clock: ten-eleven translocation enzymes and JmjC-domain histone demethylases all require oxygen as a co-substrate, so declining tissue oxygen pressure may directly accelerate the accumulation of aberrant methylation patterns characteristic of cellular senescence. Supporting this, the authors’ own recent work showed that intermittent hypoxia in old mice accelerated epigenetic age in lung, spleen, and heart by up to five months — an effect that reversed after return to normoxia. Hypoxia also reshapes the RNA splicing landscape, promoting intron retention and isoform switching that, when dysregulated by age-related transcriptomic noise, may generate aberrant proteins and neoepitopes that provoke immune surveillance.

The framework’s most provocative implications are therapeutic. The authors survey emerging gerotherapies that deliberately modulate the oxygen cascade: intermittent hypoxia, which in carefully dosed protocols activates neurotrophic BDNF-TrkB signaling and enhances motor recovery after spinal cord injury; hyperbaric oxygen therapy, which exploits the hyperoxic-hypoxic paradox — the rapid pressure drop from over two atmospheres back to sea level — to trigger HIF-1alpha signaling without true hypoxia, with preliminary reports of telomere elongation exceeding 20 percent in immune cells and clearance of senescent T cells; and intermittent hypoxic-hyperoxic training, which alternates low and high oxygen to drive mitophagy-based mitochondrial selection. The authors caution, however, that the hormetic dose-response curve likely shifts with age: interventions beneficial in young organisms may prove toxic in frail older adults whose NRF2-mediated antioxidant buffering is compromised. Sex differences, frailty, and individual variability in hypoxic ventilatory response further narrow the therapeutic window. Their prescription for the field is rigorous: define therapeutic windows tailored to biological rather than chronological age, monitor real-time biomarkers of oxidative stress and mitochondrial function during therapy, and conduct randomized controlled trials stratified by frailty status. Oxygen-sensing pathways, they argue, represent a high-leverage gerotherapeutic target — one that could help decouple chronological age from biological decay and chart a roadmap toward extending human healthspan.

Subject of Research: Age-related decline in the oxygen transport cascade and its role in the biology of aging

Article Title: Oxygenaging: A Physiological Framework for Geroscience

Article References: Donega, S., Fishbein, K. W., Dominelli, P., Herman, A. B., de Cabo, R., Gorospe, M., & Ferrucci, L. (2026). Oxygenaging: A Physiological Framework for Geroscience. Aging Cell, 25(9), Article e70664. https://doi.org/10.1111/acel.70664

Image Credits: AI Generated

DOI: 10.1111/acel.70664

Keywords: Oxygenaging, geroscience, oxygen cascade, HIF-1alpha, mitochondrial dysfunction, microvascular rarefaction, pseudohypoxia, ferroptosis, hyperbaric oxygen therapy, intermittent hypoxia, epigenetic aging, Aging Cell

Aging, the authors emphasize, is not a single number. Chronological age tells us little about how quickly any one tissue or organ system is deteriorating, which is why researchers have increasingly turned to organ-specific “biological clocks.” Epigenetic clocks, which estimate biological age from patterns of DNA methylation, have dominated this field. But muscles—the largest organ in the body and the engine of functional autonomy—follow their own nonlinear trajectory, heavily influenced by lifestyle, nutrition, and physical activity. To capture this, the research team, led by Federico Frasca, Chiara Pappalettera, Alessia Cacciotti, and Fabrizio Vecchio of the Brain Connectivity Laboratory at IRCCS San Raffaele in Rome, together with colleagues at the University of Sassari, employed a previously developed “muscle phenotypic clock.” This regression-based model quantifies muscle age (MA) from the battery of functional assessments recommended by the revised European consensus on sarcopenia, EWGSOP-2, including anthropometric estimates of muscle mass, measurements of muscle strength, and motor performance tests such as gait and mobility evaluations.

The key derived quantity is muscle age acceleration (MAA)—the difference between a person’s estimated muscle age and their chronological age. A negative value signals decelerated muscle aging, meaning muscles functionally younger than expected; a positive value signals accelerated aging, a potential early warning sign on the road to sarcopenia, the age-related loss of muscle mass and function that affects a growing share of the world’s aging population. In the new study, participants—all healthy, neurologically intact older adults screened for cognitive impairment and other exclusion criteria—were stratified into three groups based on their MAA: decelerated, normal, and accelerated muscle aging.

To probe the brain side of the equation, each participant underwent eyes-closed resting-state EEG, a century-old technique whose spontaneous rhythms have proven remarkably informative about network-level brain health. The researchers computed magnitude-squared coherence (MSCoh), a frequency-resolved measure of how strongly oscillatory activity at pairs of cortical regions fluctuates in tandem, effectively an index of functional connectivity between brain areas. They then applied graph-theoretical analysis, computing node strength—the sum of a node’s connectivity weights across the whole network—to identify which cortical regions carried the largest differences between muscle-aging groups. Statistical testing used nonparametric permutation-based procedures of the kind standard in modern EEG network science, guarding against spurious findings across the many electrodes, frequency bands, and pairwise comparisons involved.

The results were striking in both direction and topography. Participants with decelerated muscle aging—those with the biologically youngest muscles—showed significantly lower coherence than both the normal and accelerated groups in the Alpha 1 (roughly 8–10 Hz), Alpha 2 (10–12 Hz), and Beta 1 (13–20 Hz) frequency bands. In other words, the parietal and frontal networks that generate these rhythms were less tightly synchronized in people whose muscles were aging slowly. Alpha oscillations are classically associated with the brain’s attentional gating and the efficient allocation of cognitive resources, while beta rhythms are deeply involved in sensorimotor control and the maintenance of the motor status quo; both bands are known to be altered in dementia and in normal aging, where coherence typically increases, a pattern interpreted by many groups as a sign of reduced neural flexibility or compensatory neural “crosstalk.”

The node strength analysis sharpened the picture further. The decelerated MA group showed lower node strength in the right frontal area across the Alpha 1, Beta 1, and Beta 2 bands, while the normal MA group showed lower values in the right temporal region compared with the accelerated MA group. The consistent involvement of right-hemispheric frontal and temporal hubs is noteworthy. Right frontal regions are central to attentional control and executive function, and their connectivity patterns change in characteristic ways with aging and neurodegeneration. The findings align with established models of age-related network reorganization, such as the HAROLD model of hemispheric asymmetry reduction, in which older adults recruit additional homotopic regions to sustain performance. In this framework, the increased synchronization seen in people with accelerated muscle aging may represent a less efficient, more rigid network configuration—perhaps an early neural correlate of the same processes that stiffen muscles and slow gait.

What mechanism could connect the biological age of muscle to the topology of brain networks? The authors and the broader literature point to several converging pathways. Skeletal muscle is not merely a mechanical engine; it is an endocrine organ that secretes myokines during contraction, molecules such as irisin and interleukin-6 variants that influence neuroplasticity, inflammation, and metabolism. Conversely, the corticospinal drive from the motor cortex shapes the very muscle activity that maintains muscle mass, and recent work has suggested that deteriorating corticospinal control may itself be a determinant of sarcopenia. Chronic low-grade inflammation—termed “inflammaging”—is a shared driver of both muscle wasting and cognitive decline, and clinical studies have repeatedly linked sarcopenia to white matter hyperintensities, cognitive impairment, and dementia risk. The new study is distinctive in that it avoids the confounding presence of diagnosed disease: all participants were healthy, meaning the brain-network differences reflect a graded, subclinical gradient of body-brain aging within the normal older population.

Methodologically, the study is notable for its attempt to quantify an organ’s biological age using purely phenotypic, clinically accessible measures. The muscle phenotypic clock, developed by the Sassari group in earlier cross-sectional work on middle-aged and older adults, was built with regularized regression techniques—the elastic net of Zou and Hastie, implemented in machine-learning toolchains such as scikit-learn—combining anthropometrics, bioelectrical estimates of skeletal muscle mass, grip strength and other strength measures, and standardized motor tests including the timed Up-and-Go and the six-minute walk protocol. Because these measures can be gathered in any geriatric clinic, the approach sidesteps the cost and invasiveness of epigenetic sequencing, raising the prospect that a routine functional assessment could one day yield both a muscle age score and, if corroborated by future work, a noninvasive window into brain network health.

The clinical implications cut in both directions. First, MAA could serve as a low-cost screening variable that flags older adults whose brain networks may already be drifting toward the hyper-synchronous patterns associated with cognitive vulnerability, well before symptoms appear. Second, and perhaps more provocatively, the findings suggest that interventions designed to slow muscle aging—progressive resistance training, adequate protein intake, physical activity programs—might do double duty by favorably reshaping brain connectivity. Previous EEG studies have shown that resting-state connectivity predicts motor skill learning and responds to rehabilitation after stroke, and integrated motor-cognitive training programs are increasingly advocated for frail older adults. If muscle age acceleration truly shapes brain network topography, then redirecting that trajectory becomes not merely a matter of preserving mobility but of protecting the brain itself.

The authors are careful to frame the study as hypothesis-generating. It is cross-sectional, so causality cannot be established: accelerated muscle aging might drive brain changes, brain changes might drive muscle decline, or a third factor such as systemic inflammation might drive both. The cohort, while carefully characterized, is limited in size, and EEG coherence reflects only cortical, predominantly radial, current sources rather than the full three-dimensional complexity of brain network dynamics. Longitudinal studies tracking MAA and EEG networks in the same individuals over years, ideally combined with measures of cognitive trajectory and blood-based biomarkers, will be needed to determine whether the muscle clock can predict future brain decline and whether interventions that decelerate muscle aging produce measurable, beneficial shifts in resting-state connectivity.

Even with those caveats, the study lands at a moment of intense interest in biological age clocks and in the muscle–brain axis. The idea that “muscle age” is not just a poetic phrase but a quantifiable, clinically meaningful variable—one that leaves an electrical signature in the resting brain—is likely to energize both the geroscience and neurorehabilitation communities. For a global population aging at unprecedented speed, the promise of a single clinic visit that yields a muscle age, an early read on brain network health, and a personalized prescription of exercise and nutrition is an alluring one. This study offers the first EEG-based evidence that the trajectory of muscle aging and the architecture of resting brain networks are systematically intertwined in healthy older people, and it points toward an era in which keeping the body’s largest organ young may be among the most effective strategies for keeping the brain young too.

The emphasis of the research is on epigenetic aging, which pertains to the biological age of an individual as determined by changes in DNA methylation. DNA methylation is a chemical modification of DNA that plays a significant role in gene regulation and expression. As individuals age, the patterns of methylation change, which can reflect the overall health and aging process within the body. This study found that women with heightened biological age as indicated by their DNA methylation profiles had an increased likelihood of developing breast cancer, suggesting a direct connection between accelerated epigenetic aging and cancer risk.

The subject of this investigation specifically focuses on postmenopausal, non-Hispanic white women, a demographic known to face elevated breast cancer risks especially after menopause. The researchers conducted a detailed analysis of blood samples and discovered a stark correlation: women whose biological markers indicated they were aging more rapidly were statistically more likely to be diagnosed with breast cancer. Intriguingly, this risk was amplified in women who had undergone bilateral oophorectomy before natural menopause, an operation that results in a significant reduction of estrogen levels – a hormone integral to maintaining both breast health and overall physiological processes.

Understanding how estrogen plays a role in both aging and cancer susceptibility is critical. The study suggests that diminished lifetime estrogen exposure directly contributes to the acceleration of aging markers in women, thereby influencing their vulnerability to breast cancer. This finding is particularly relevant for health practitioners and researchers as it underlines the need for tailored approaches in assessing cancer risks in different populations of women, particularly those with varied reproductive histories.

Furthermore, the findings extend beyond biological demographics, as lifestyle factors significantly impact both epigenetic aging and breast cancer susceptibility. The research indicates that obesity is linked to accelerated biological aging, thereby further heightening the cancer risk in obese women. Conversely, the effects of hormone replacement therapy varied depending on the regimen’s type and duration, illustrating the complex relationship between hormonal interventions and cancer risk.

One of the key takeaways from this research is the potential for early detection, which remains a cornerstone of effective breast cancer treatment. The current framework for assessing breast cancer risk often includes conventional factors such as age, family history, and lifestyle habits; however, these determinants may not provide a comprehensive overview of an individual’s actual risk. By integrating a blood test that measures biological aging into the risk assessment protocol, clinicians may better identify high-risk individuals and develop personalized prevention strategies.

As the study points out, utilizing this blood test for routine health screenings for women could revolutionize how healthcare providers approach breast cancer detection. The practical implications are profound, providing women with actionable insights into their health that can empower them to take proactive steps in mitigating risk through healthy lifestyle changes. Enhancing awareness around epigenetic aging could lead to more effective health campaigns promoting balanced diets, regular physical activity, and medically supervised hormone therapies.

Although the findings present promising advancements in breast cancer risk assessment, the authors caution that additional studies are imperative. There remains a need for validation of these findings in broader and more diverse populations to establish the universal applicability of this blood test approach. However, this innovative research offers a non-invasive, cost-effective strategy to predict breast cancer risks, highlighting the intricate connections between genetic health, environmental influences, and disease susceptibility.

In summary, the study advances an intriguing narrative on the importance of biological aging in understanding breast cancer risk, particularly among older women. The exploration of DNA methylation and its implications for epigenetic aging provides new avenues for future research and potential applications in routine medical practice. There lies a collective responsibility among researchers, clinicians, and public health advocates to glean insights from these findings, aiming to enhance breast cancer prevention strategies that could ultimately save lives.

With the continued research into the applications of epigenetic markers in cancer risk evaluation, healthcare may witness a transformative approach to managing breast cancer, leading to safer, more informed health practices for women worldwide.

Subject of Research:
Article Title: DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility
News Publication Date: January 21, 2025
Web References:
References:
Image Credits: © 2024 Jung et al.

Keywords: aging, DNA methylation-based marker of aging, pre-diagnostic DNA, breast cancer, tumorigenesis, postmenopausal women